APLS Apellis Pharmaceuticals, Inc.
$41.01
▼ 0.27%
49
Value
33
P/E38.78
32
P/B12.46
39
P/S5.10
46
EV/EBITDA28.04
17
Growth
72
Revenue Growth28.5%
100
EPS Growth111.3%
51
FCF Growth151.0%
61
Momentum
82
12-Month Return114.5%
100
3-Month Return81.8%
100
1-Month Return0.8%
55
RSI (14)60.78
70
50/200 MABullish
75
Profitability
50
ROE39.7%
59
ROA12.3%
66
Gross Margin89.4%
72
Operating Margin16.1%
43
Net Margin13.0%
46
FCF Yield0.7%
17
Risk
9
Beta-0.25
20
60-Day Volatility178.4%
0
QScore Analysis